Audience

Read by all 50 of the biggest Pharma companies, like Pfizer and Novartis, as well as thousands of innovative, clinical-stage biotechs.

OUR PLATFORMS draw

252k+
daily email subscribers
700K+
unique monthly visitors
1.8M
average monthly page views
70K+
event registrations

OUR SUBSCRIBERS count

OUR SUBSCRIBERS span

OUR TOP STORIES include

Lilly and Novo near White House deal on obesity drug prices
November 4, 2025
Updated: Pfizer triumphs over Novo Nordisk with $10B bid for Metsera
November 8, 2025
China lifts import ban on Illumina's DNA sequencers as trade tensions ease
November 5, 202
Updated: Novo Nordisk raises Metsera bid again, hoping to top Pfizer's latest offer
November 6, 2025
Sarepta's Duchenne confirmatory trial fails, but biotech will ask FDA for full approval anyway
November 3, 2025

Get started

Connect with us to request a media kit and learn more about rates and availability.

Julie O'Meara
Julie O'Meara
Executive Director, Brand Partnerships, Endpoints News
Melissa Nazzaro